EUVIMEDEUVIMED entdecken
Crossref

A Customized Defense: Bispecific Antibodies Binding Functional Domains in the S1 and S2 Subunits of the SARS-CoV-2 Spike Glycoprotein

Megan Parada, Christopher O. Barnes, Peter S. Kim, Stanford University

Stanford Digital Repository · 01.05.2026

DOI: 10.25740/fh356nr4157 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stanford Digital Repository, erschienen am 01.05.2026. Verfasst von Megan Parada und 3 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As evidenced by the COVID-19 pandemic, the causative virus, SARS-CoV-2, is at the root of global health emergencies and continues to spread, posing various threats to human health. The continuous evolution of SARS-CoV-2 drives the emergence of different variants of concern (VOCs) that evade many existing antibody therapeutics. The viral spike (S) glycoprotein remains a primary target due to its essential role in mediating membrane fusion and viral entry into host cells. This study tests the hypothesis that simultaneously targeting multiple epitopes on the S protein enhances neutralization potency and breadth. Accordingly, specificities for two distinct epitopes on the S protein, the amino-terminal domain (NTD) and receptor binding domain (RBD), were first combined using bispecific antibodies (bsAbs) designed to increase avidity and limit viral escape from selective pressure. The bsAb constructs were designed and engineered by subcloning single-chain variable fragments (scFvs) derived from previously identified antibodies into tandem formats, with expression in mammalian cells. In this project, binding to a broad panel of variants was characterized using enzyme-linked immunosorbent assays (ELISAs) and biolayer interferometry (BLI), followed by subsequent evaluation of neutralization potency using lentiviral pseudotype assays. Remarkably, the bsAbs retained neutralization efficacy against divergent Omicron VOCs, outperforming the reduced potency seen for monoclonal antibodies. This bispecific strategy was extended to conserved epitopes shared across SARS-CoV-2 VOCs and the main coronavirus genera, termed coldspots, within the Stem Helix (SH) and Lower Stalk (LS). We additionally resolved the X-ray crystal structure of a LS Fab, expanding the limited structural knowledge about antibodies to this region and guiding subsequent LS-directed investigation. The same principle demonstrated by NTD-RBD constructs did not translate for the LS-SH bsAbs, suggesting the biological mechanisms governing these epitopes remain insufficiently understood and warrant further study to guide bsAb design. Collectively, this study provides a framework for next-generation bsAbs, highlighting the therapeutic potential of NTD-RBD designs while informing future optimization of coldspot targeting strategies against current and future coronavirus strains.

Schlagwörter

bispecific antibodiesSARS-CoV-2 spike proteinneutralizing antibodiesOmicron variantreceptor binding domainN-terminal domainantibody escapeantibody engineeringscFvantibody crystal structure

Zitieren

APA

Parada, M., Barnes, C. O., Kim, P. S., & University, S. (2026). A Customized Defense: Bispecific Antibodies Binding Functional Domains in the S1 and S2 Subunits of the SARS-CoV-2 Spike Glycoprotein. Stanford Digital Repository. https://doi.org/10.25740/fh356nr4157

Vancouver

Parada M, Barnes CO, Kim PS, University S. A Customized Defense: Bispecific Antibodies Binding Functional Domains in the S1 and S2 Subunits of the SARS-CoV-2 Spike Glycoprotein. Stanford Digital Repository. 2026. doi:10.25740/fh356nr4157

BibTeX
@article{Parada2026,
  author = {Parada, Megan and Barnes, Christopher O. and Kim, Peter S. and University, Stanford},
  title = {A Customized Defense: Bispecific Antibodies Binding Functional Domains in the S1 and S2 Subunits of the SARS-CoV-2 Spike Glycoprotein},
  journal = {Stanford Digital Repository},
  year = {2026},
  doi = {10.25740/fh356nr4157}
}
Kostenlos starten →